L. Villanueva

发表

Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation

J. Prieto, J. Oyarzábal, P. Coffer, 2015, The Journal of Immunology.

Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

J. Prieto, C. Leclerc, P. Berraondo, 2012, International journal of cancer.

Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.

J. Prieto, C. Leclerc, J. Lasarte, 2012, Vaccine.

DNA methylation-associated dysregulation of transfer RNA expression in human cancer

M. Esteller, Alberto Bueno-Costa, L. Villanueva, 2022, Molecular cancer.

StimulationEnhances T Cell Function after TCR Inhibition of FOXP3/NFAT Interaction

J. Oyarzábal, P. Coffer, S. Hervás-Stubbs, 2015 .

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance

J. Prieto, G. Missale, J. Lasarte, 2016, Journal of medical virology.

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

J. Prieto, B. Sangro, J. Lasarte, 2015, Molecular therapy. Methods & clinical development.

The Contribution of Epigenetics to Cancer Immunotherapy.

M. Esteller, L. Villanueva, D. Alvarez-Errico, 2020, Trends in immunology.

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

V. Trochon-Joseph, B. Sangro, J. Lasarte, 2018, Cancer Immunology, Immunotherapy.

Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies

M. Fraga, M. Esteller, M. Juan, 2021, Journal of the National Cancer Institute.

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma

B. Sangro, J. Lasarte, A. Lujambio, 2020, Cancers.

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

José L Carrascosa, Teresa Lozano, Pablo Sarobe, 2017, Oncoimmunology.

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?

A. Prat, F. Salvador, J. Cejalvo, 2022, Cancer treatment reviews.

A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo

J. Prieto, J. Lasarte, P. Sarobe, 2013, BioMed research international.

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

P. Romero, J. Carrascosa, S. Hervás-Stubbs, 2020, Journal for immunotherapy of cancer.

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

S. Hervás-Stubbs, J. Lasarte, E. Guruceaga, 2016, Oncotarget.

Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis.

R. Dienstmann, F. Salvador, E. Ciruelos, 2022, Cancer treatment reviews.

DNA methylation-associated dysregulation of transfer RNA expression in human cancer

M. Esteller, Alberto Bueno-Costa, L. Villanueva, 2022, Molecular Cancer.